Clinical Trials Browser

Terminated × Lymphoma × RRx-001 × Clear all

NCT02096341 2016-01-21

A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001

Phase 1 Terminated

Lymphoma